Sign In
Buy AMPH
$18.12
-0.330 (-1.79%)
At Close: Jun 03, 2026
Amphastar Pharmaceuticals (AMPH) is a Great Momentum Stock: Should You Buy?
01:10pm, Wednesday, 26'th Jul 2023
Does Amphastar Pharmaceuticals (AMPH) have what it takes to be a top stock pick for momentum investors? Let's find out.
5 Must-Buy High-Flying Mid-Caps to Enhance Your Portfolio
10:37am, Wednesday, 19'th Jul 2023
We have narrowed our search to five mid-cap stocks with more than 50% returns year to date. These are: PGTI, SHAK, IDCC, ANF, AMPH.
Amphastar (AMPH) is an Incredible Growth Stock: 3 Reasons Why
02:04pm, Wednesday, 12'th Jul 2023
Amphastar (AMPH) is well positioned to outperform the market, as it exhibits above-average growth in financials.
3 Profitable Stocks Worth Investing in Using Net Income Ratio
10:08am, Friday, 07'th Jul 2023
PDD Holdings (PDD), Amphastar Pharmaceuticals (AMPH) and Suzano (SUZ) are some of the top picks with a high net income ratio.
Amphastar Pharmaceuticals (AMPH) Is Up 0.54% in One Week: What You Should Know
01:02pm, Wednesday, 05'th Jul 2023
Does Amphastar Pharmaceuticals (AMPH) have what it takes to be a top stock pick for momentum investors? Let's find out.
Promising Small Biotech Amphastar Sees Actionable Pullback
08:36am, Wednesday, 28'th Jun 2023
Amphastar Pharmaceuticals Inc. NASDAQ: AMPH, a small cap that's one of the leading performers within the biotech space, is forming an orderly pullback and is currently actionable as it holds above its
3 Reasons Growth Investors Will Love Amphastar (AMPH)
02:16pm, Monday, 26'th Jun 2023
Amphastar (AMPH) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Are Medical Stocks Lagging Amphastar Pharmaceuticals (AMPH) This Year?
11:09am, Friday, 23'rd Jun 2023
Here is how Amphastar Pharmaceuticals (AMPH) and Arbutus Biopharma (ABUS) have performed compared to their sector so far this year.
4 Top-Ranked Profitable Stocks to Buy Using Net Income Ratio
07:16am, Tuesday, 20'th Jun 2023
PDD Holdings Inc. (PDD), Tecnoglass (TGLS), Amphastar Pharmaceuticals (AMPH) and Axon Enterprise (AXON) have been selected as the top picks with a high net income ratio.
Here is Why Growth Investors Should Buy Amphastar (AMPH) Now
01:53pm, Thursday, 08'th Jun 2023
Amphastar (AMPH) possesses solid growth attributes, which could help it handily outperform the market.
Is Amphastar Pharmaceuticals (AMPH) Stock Outpacing Its Medical Peers This Year?
10:48am, Wednesday, 07'th Jun 2023
Here is how Amphastar Pharmaceuticals (AMPH) and Arbutus Biopharma (ABUS) have performed compared to their sector so far this year.
4 Solid Profitable Stocks to Invest in Using Net Income Ratio
08:53am, Friday, 02'nd Jun 2023
Tecnoglass (TGLS), Amphastar Pharmaceuticals (AMPH), Turkcell Iletisim Hizmetleri (TKC) and Copa Holdings (CPA) have been selected as the top picks with a high net income ratio.
Amphastar Pharmaceuticals to Present at the Jefferies Healthcare Conference
04:15pm, Wednesday, 31'st May 2023
RANCHO CUCAMONGA, CA / ACCESSWIRE / May 31, 2023 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Dan Dischner SVP of Corp. Communication, will participate in
Looking for a Growth Stock? 3 Reasons Why Amphastar (AMPH) is a Solid Choice
01:54pm, Tuesday, 23'rd May 2023
Amphastar (AMPH) possesses solid growth attributes, which could help it handily outperform the market.
3 Generic Drug Stocks to Watch Amid Macro Headwinds
09:08am, Tuesday, 23'rd May 2023
The impact of macroeconomic headwinds on the Zacks Medical - Generic Drugs industry persists. New product launches provide some respite to AMPH, RDY and TEVA.
